Tesamorelin
Targeting Belly Fat and Metabolism
WHAT IT IS:
A peptide analog of growth hormone–releasing hormone (GHRH) that signals the pituitary gland to release the body’s own growth hormone in its natural bio-rhythm to reduce excess deep abdominal fat.
WHY YOU NEED IT:
Targeted Support for Stubborn Visceral (Belly) Fat
Important for patients carrying excess deep abdominal fat that resists diet and exercise
Supports patients seeking improved body composition and a smaller waistline
Good for patients with metabolic concerns such as fatty liver (NAFLD) and insulin resistance
Great for patients pursuing healthy aging who want to restore more youthful growth-hormone signaling
Supports patients interested in the lipid-profile and cognitive benefits reported in research
Important for patients who want a physician-guided protocol that preserves natural hormonal feedback
HOW IT HELPS:
Growth hormone naturally declines with age, while excess visceral fat quietly drives many metabolic problems. Tesamorelin works upstream: instead of replacing growth hormone directly, it encourages the body to make and release its own.
A Precision GHRH Analog
Tesamorelin is a peptide analog of growth hormone–releasing hormone. It binds GHRH receptors on the pituitary and prompts a natural release of growth hormone, raising IGF-1 while leaving the body’s own feedback loops intact.
Proven Visceral Fat Reduction
FDA-approved in 2010 (Egrifta®- a similar Tesamorelin-like peptide molecule) for HIV-associated belly and chest fat accumulation. Tesamorelin has been shown in clinical trials to selectively reduce visceral adipose tissue — the metabolically active fat deep in the abdomen. It has also been investigated for non-alcoholic fatty liver disease (NAFLD), insulin sensitivity, cholesterol management, and cognitive function.
Who Should Not Use Tesamorelin
Tesamorelin is not appropriate for patients with active or high-risk malignancy (growth hormone is a growth signal), women who are pregnant or breastfeeding, patients with disruption of the pituitary/hypothalamic axis, or those with a known hypersensitivity. Because growth hormone can raise blood sugar, use caution and monitor glucose in patients with diabetes or insulin resistance.
DOSAGE
Titration: Physician-advised microdosing and cycling is key to successful use of Tesamorelin.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.